Beast Ventures

Baseimmune is a biotech startup focused on developing next-generation vaccines. The company has created a platform for pathogen analysis that facilitates the design of antigens and vaccines. Utilizing innovative technology, Baseimmune's platform generates antigens through a sophisticated level of informatics, which addresses emerging and challenging pathogens. This approach allows healthcare providers to maintain vaccine efficacy, even in the face of pathogen mutations. By prioritizing advanced solutions in vaccine development, Baseimmune aims to enhance public health responses to infectious diseases.

Nutropy specializes in producing real milk ingredients that are identical to those produced by cows, focusing on creating premium cheese alternatives. These alternatives offer the same taste experience as traditional cow's cheese but are more sustainable, healthier, and do not involve any animal exploitation. The company achieves this by manufacturing dairy proteins equivalent to cow proteins using microbes and fermentation processes. Nutropy's products are designed for large-scale dairy applications in the global cheese market, enabling businesses to produce mass-market items with a significantly lower carbon footprint and reduced environmental impact.

Baseimmune is a biotech startup focused on developing next-generation vaccines. The company has created a platform for pathogen analysis that facilitates the design of antigens and vaccines. Utilizing innovative technology, Baseimmune's platform generates antigens through a sophisticated level of informatics, which addresses emerging and challenging pathogens. This approach allows healthcare providers to maintain vaccine efficacy, even in the face of pathogen mutations. By prioritizing advanced solutions in vaccine development, Baseimmune aims to enhance public health responses to infectious diseases.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive food analytics platform that utilizes next-generation sequencing and data analytics to enhance food safety and quality control. Its offerings include Clear Dx™ and Clear Safety™, which facilitate the rapid identification of pathogens and support public health initiatives. Clear Labs' platform delivers critical insights into the molecular composition of foods and ingredients, testing for authenticity, contaminants, allergens, and other safety parameters. By offering transparency across supply chains, the company serves food manufacturers, suppliers, and retailers, enabling them to improve operational efficiency and safety through detailed analytics and reporting.

LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Sparrho is a London-based company that operates a discovery platform designed to make scientific information more accessible. Founded in 2013 by two Oxbridge scientists, the platform aggregates, distills, and recommends relevant content from a wide array of scientific sources, including journals, patents, and conference materials. It offers customized, filtered recommendations to users, allowing them to add content and sources, as well as save, share, and disseminate discoveries. By leveraging a unique combination of artificial intelligence and expertise from PhD professionals, Sparrho enhances the literature search experience and caters to a diverse clientele, including Fortune 500 companies around the world. The company was previously known as Epistora.

Q Bio, Inc., established in 2015, develops a comprehensive health assessment platform that combines advanced non-invasive imaging, genetic testing, vital signs, and medical history to provide a snapshot of an individual's health. The company's flagship product, Q BioVault, aggregates and summarizes an individual's entire medical history, identifying and tracking significant health changes. Q Bio's interdisciplinary team, based in San Carlos, California, comprises experts in applied math, computational physics, electrical engineering, genetics, and radiology. Backed by prominent venture capital firms, the company aims to empower healthcare professionals with proactive, data-driven insights to improve patient outcomes.